Elevance Capital Surpluse from 2010 to 2025

ELV Stock  USD 423.64  3.59  0.84%   
Elevance Health Capital Surpluse yearly trend continues to be fairly stable with very little volatility. Capital Surpluse will likely drop to about 7.8 B in 2025. During the period from 2010 to 2025, Elevance Health Capital Surpluse regression line of quarterly data had mean square error of 626472.6 T and geometric mean of  9,477,007,194. View All Fundamentals
 
Capital Surpluse  
First Reported
2010-12-31
Previous Quarter
8.8 B
Current Value
8.8 B
Quarterly Volatility
1.1 B
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Elevance Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elevance Health's main balance sheet or income statement drivers, such as Interest Expense of 1.2 B, Total Revenue of 185.7 B or Gross Profit of 164.9 B, as well as many indicators such as Price To Sales Ratio of 0.46, Dividend Yield of 0.0156 or PTB Ratio of 1.51. Elevance financial statements analysis is a perfect complement when working with Elevance Health Valuation or Volatility modules.
  
Check out the analysis of Elevance Health Correlation against competitors.
For more information on how to buy Elevance Stock please use our How to Invest in Elevance Health guide.

Latest Elevance Health's Capital Surpluse Growth Pattern

Below is the plot of the Capital Surpluse of Elevance Health over the last few years. It is Elevance Health's Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Elevance Health's overall financial position and show how it may be relating to other accounts over time.
Capital Surpluse10 Years Trend
Slightly volatile
   Capital Surpluse   
       Timeline  

Elevance Capital Surpluse Regression Statistics

Arithmetic Mean9,551,182,083
Geometric Mean9,477,007,194
Coefficient Of Variation13.33
Mean Deviation955,148,698
Median9,244,000,000
Standard Deviation1,273,626,390
Sample Variance1622124.2T
Range5.1B
R-Value(0.80)
Mean Square Error626472.6T
R-Squared0.64
Significance0.0002
Slope(213,935,441)
Total Sum of Squares24331862.7T

Elevance Capital Surpluse History

20257.8 B
20248.2 B
20229.1 B
20219.1 B
20209.2 B
20199.4 B
20189.5 B

About Elevance Health Financial Statements

Elevance Health investors use historical fundamental indicators, such as Elevance Health's Capital Surpluse, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Elevance Health. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Capital Surpluse8.2 B7.8 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Elevance Stock Analysis

When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.